Cytotoxin Compound and Method of Isolation

The present invention concerns compounds derived from tunicates of the species Synoicum adareanum, as well as to pharmaceutical compositions comprising these compounds and methods of use. Extracts from tunicates show selective toxicity against several different cancer cell lines in the NCI 60 cell line panel. These compounds are useful in the effective treatment of cancers, particularly malignant melanomas, colon cancer, and renal cancer cell lines.

Patents:
US 9,394,270 issued 2016-07-19   [MORE INFO]
US 7,625,885 issued 2009-12-01   [MORE INFO]

Inventor(s): BAKER BILL J [US]; DIYABALANAGE THUSHARA [US]; MCCLINTOCK JAMES B [US]; AMSLER CHARLES D [US]

Type of Offer: Licensing



« More Biotech Patents

---